By contrast, even after successful completion of the standard course of 6 months of anti-TB treatment, expression of Bcl-2 and CD127 by CFP-10/ESAT-6-specific CD8 T cells of TB disease patients remained significantly lower than in persons with LTBI (Figure 4F–G). Here, BCL2 is linked to tuberculosis.